Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 1;7(4):00384-2021.
doi: 10.1183/23120541.00384-2021. eCollection 2021 Oct.

Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort

Affiliations

Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort

David Ross Darley et al. ERJ Open Res. .

Abstract

In a longitudinal cohort, a significant proportion of patients had persistent symptoms 8 months after initial #COVID19 infection. There was no significant improvement in symptoms or health-related quality of life between 4- and 8-month assessments. https://bit.ly/2Wtb7IX.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D.R. Darley has nothing to disclose. Conflict of interest: G.J. Dore reports grants from Gilead, Abbvie, Merck and Bristol-Myers Squibb, personal fees from Gilead, Abbvie and Merck, and nonfinancial support from Gilead, Abbvie and Merck, outside the submitted work. Conflict of interest: A.L. Byrne has nothing to disclose. Conflict of interest: M.L. Plit has nothing to disclose. Conflict of interest: B.J. Brew reports grants from St Vincent's Clinic during the conduct of the study; and personal fees from AbbVie, Janssen and Viiv, and grants from Biogen, outside the submitted work. Conflict of interest: A. Kelleher has nothing to disclose. Conflict of interest: G.V. Matthews has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Proportion of patients with symptoms at acute coronavirus disease 2019 (COVID-19) infection compared with 4 months and 8 months after assessment (n=66).

References

    1. Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27: 626–631. doi:10.1038/s41591-021-01292-y - DOI - PMC - PubMed
    1. Townsend L, Dyer AH, Jones K, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE 2020; 15: e0240784. doi:10.1371/journal.pone.0240784 - DOI - PMC - PubMed
    1. Carfi A, Bernabei R, Landi F, et al. . Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603–605. doi:10.1001/jama.2020.12603 - DOI - PMC - PubMed
    1. Darley DR, Dore GJ, Cysique L, et al. . High rate of persistent symptoms up to 4 months after community and hospital-managed SARS-CoV-2 infection. Med J Aust 2020; 214: 279–280. doi:10.5694/mja2.50963 - DOI - PMC - PubMed
    1. Hickie IB, Davenport TA, Hadzi-Pavlovic D, et al. . Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175: S10–S17. doi:10.5694/j.1326-5377.2001.tb143784.x - DOI - PubMed

LinkOut - more resources